An interventional study to access the effect of Ayurvedic medicine ASA-20 as a prohylaxis in high risk population exposed to COVID-19

A prospective interventional study on the effect of ASA-20(Ayush kwath, Samsamani vati, Anu taila) as a prophylaxis measure among High risk population exposed to COVID-19 - ASA-20

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/026055

Enrollment

5000

Registered

2020-06-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: ASA-20: Ayush kwath- 3gm twice daily after food Samsamani Vati- 500 mg twice daily after food Anu taila- 2 drops twice daily in each nostril The total duration of Ayurveda intervention

Eligibility

Inclusion criteria

Inclusion criteria: 1 Subjects of high risk population 2 Male or female subjects above the age of 15 years to 70 years. 3 Subjects who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study.

Exclusion criteria

Exclusion criteria: 1 Pregnant and Lactating woman 2 Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening. 3 Subjects who are on any regular medication(alternative/modern) for any other ailments. 4 Subjects participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study. 5 Subjects having a past history of allergy to any medicine that is part of the Ayurvedic intervention. Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrollment or could interfere with his participation in, and completion of the protocol.

Design outcomes

Primary

Measure	Time frame
To assess the occurrence of COVID-19 infection in healthy volunteers exposed to COVID-19 in the communityTimepoint: 6 MONTHS	—

Secondary

Measure	Time frame
1 To assess the immunity status of the participants taking ASA-20. 2 To evaluate the occurrence of adverse event for safety assessment of ASA-20. Timepoint: 6 MONTHS	—

Countries

India

Contacts

Public ContactDr Sikha Lekharu

North Eastern Institute of ayurveda and homoeopathy

shikhalekharu@gmail.com8811834122

Outcome results